Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
Author:
Publisher
Oxford University Press (OUP)
Subject
Internal Medicine
Link
http://academic.oup.com/ajh/article-pdf/23/2/192/6630942/23_2_192.pdf
Reference25 articles.
1. Tackling heart failure in the twenty-first century
2. Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment
3. Controversies in ventricular remodelling
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiovascular risk of dietary trimethylamine oxide precursors and the therapeutic potential of resveratrol and its derivatives;FEBS Open Bio;2024-01-21
2. Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents;Pharmaceuticals;2023-10-12
3. Oat Beta-Glucan Alone and in Combination with Hydrochlorothiazide Lowers High Blood Pressure in Male but Not Female Spontaneously Hypertensive Rats;Nutrients;2023-07-18
4. Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice;J PHARMACOL SCI;2023
5. Cellular battle against endoplasmic reticulum stress and its adverse effect on health;Life Sciences;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3